In the last trading session, 0.52 million shares of the C4 Therapeutics Inc (NASDAQ:CCCC) were traded, and its beta was 3.11. Most recently the company’s share price was $1.62, and it changed around -$0.12 or -6.90% from the last close, which brings the market valuation of the company to $115.03M. CCCC currently trades at a discount to its 52-week high of $7.66, offering almost -372.84% off that amount. The share price’s 52-week low was $1.09, which indicates that the current value has risen by an impressive 32.72% since then.
C4 Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.89. If we narrow it down even further, the data shows that 0 out of 9 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 4 recommended CCCC as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight.
C4 Therapeutics Inc (NASDAQ:CCCC) trade information
Instantly CCCC has showed a red trend with a performance of -6.90% at the end of last trading. The rise to weekly highs of 1.7900 on recent trading dayincreased the stock’s daily price by 9.5%. On the other hand, C4 Therapeutics Inc (NASDAQ:CCCC) is 17.82% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $12, which translates to bulls needing to increase their stock price by 86.5% from its current value. Analyst projections state that CCCC is forecast to be at a low of $12 and a high of $12.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -8.92%. C4 Therapeutics Inc earnings are expected to increase by -19.20% in 2025, but the outlook is positive 1.33% per year for the next five years.
CCCC Dividends
C4 Therapeutics Inc’s next quarterly earnings report is expected to be released on 2025-Feb-26.
RA CAPITAL MANAGEMENT, L.P., with 7.0891% or 4.88 million shares worth $22.54 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
WASATCH FUNDS TRUST-Wasatch Ultra Growth Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 3.38 shares worth $5.48 million, making up 4.76% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 2.07 shares worth around $3.36 million, which represents about 2.92% of the total shares outstanding.